SCHEMBL8205498

SCHEMBL8205498

CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1O[C@@H]1C(=O)NCCc1cnccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 2/20 0.43
MMP8 P22894 2/20 0.43
MMP14 P50281 1/20 0.43
PSMB5 P28074 10/20 0.43
PSMB1 P20618 7/20 0.43
PSMB2 P49721 7/20 0.43
CTSL P07711 1/20 0.43
KMT2A Q03164 1/20 0.42
LONP1 P36776 8/20 0.39
PSMB11 A5LHX3 6/20 0.39
PSMA7 O14818 6/20 0.39
PSMA1 P25786 6/20 0.39
PSMA2 P25787 6/20 0.39
PSMA3 P25788 6/20 0.39
PSMA4 P25789 6/20 0.39
PSMB8 P28062 6/20 0.39
PSMB9 P28065 6/20 0.39
PSMA5 P28066 6/20 0.39
PSMB4 P28070 6/20 0.39
PSMB6 P28072 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211686 1.00 MMP9 (0.43) MMP9MMP8MMP14PSMB5PSMB1
SCHEMBL7207300 0.90 KMT2A (0.53) MMP9MMP8MMP14KMT2APYGL
SCHEMBL14513402 0.90 KMT2A (0.53) MMP9MMP8MMP14KMT2APYGL
SCHEMBL29706360 0.90 KMT2A (0.53) MMP9MMP8MMP14KMT2APYGL
SCHEMBL7207304 0.90 KMT2A (0.53) MMP9MMP8MMP14KMT2APYGL
SCHEMBL7203960 0.85 MMP9 (0.53) MMP9MMP8MMP14PSMB5PSMB1
SCHEMBL7203966 0.85 MMP9 (0.53) MMP9MMP8MMP14PSMB5PSMB1
SCHEMBL7211704 0.85 MMP9 (0.43) MMP9MMP8MMP14KMT2APYGL
SCHEMBL7211698 0.85 MMP9 (0.43) MMP9MMP8MMP14KMT2APYGL
SCHEMBL7204605 0.84 MMP9 (0.44) MMP9MMP8MMP14KMT2APYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed